<DOC>
	<DOCNO>NCT01393119</DOCNO>
	<brief_summary>The purpose study determine appropriate load maintenance dose GTx-758 reach maintain castration duration study .</brief_summary>
	<brief_title>Phase II , Dose Finding Study GTx-758</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>1 . Be age 45 80 year age 2 . Be able communicate effectively study personnel 3 . ECOG ≤2 4 . Screening serum total testosterone ≥150 ng/dL 5 . Have prostate cancer , confirm pathology report 6 . Have treat ADT ( chemical surgical ) . If subject treat LHRHa ≤6 month duration treatment ≥1 year prior screen , subject may consider study . 7 . Have clinical indication initiation ADT . 8 . Give write informed consent prior study specific procedures 9 . Subjects must agree use acceptable method contraception : If female partner pregnant lactate acceptable method contraception time first administration study medication 3 month follow administration last dose study medication must use . Acceptable method : Condom use spermicidal foam/gel/film/cream/suppository . If subject undergone surgical sterilization ( vasectomy documentation azospermia ) condom spermicidal foam/gel/film/cream/suppository use . If male subject 's partner could become pregnant , use acceptable method contraception time first administration study medication 3 month follow administration last dose study medication . Acceptable method contraception follow : Condom spermicidal foam/gel/film/cream/suppository [ i.e . double barrier method contraception ] , surgical sterilization ( vasectomy documentation azospermia ) double barrier method ( condom use spermicidal foam/gel/film/cream/suppository ) , female partner use oral contraceptive ( combination estrogen/progesterone pills ) , injectable progesterone subdermal implant double barrier method ( condom use spermicidal foam/gel/film/cream/suppository ) . If female partner undergone document tubal ligation ( female sterilization ) , double barrier method ( condom use spermicidal foam/gel/film/cream/suppository ) also use . If female partner undergone document placement intrauterine device ( IUD ) intrauterine system ( IUS ) , double barrier method ( condom spermicidal foam/gel/film/cream/suppository ) also use . 1 . Known hypersensitivity allergy estrogen estrogen like drug 2 . Have , judgment Investigator , clinically significant concurrent illness psychological , familial , sociological , geographical concomitant condition would permit adequate followup compliance study protocol 3 . History abnormal blood clotting , Factor V Leiden clot disorder , thrombotic disease ( venous arterial thrombotic event history myocardial infarct ( MI ) , stroke , deep vein thrombosis ( DVT ) , and/or pulmonary embolus ( PE ) ) NOTE : evidence MI ECG document medical history history MI great three year ago completely resolve , eligibility subject per exclusion criterion investigator decision may require consultation cardiologist . 4 . Have ALT AST 2 time upper limit normal ( ULN ) 5 . Have alkaline phosphatase great 3 time ULN and/or total bilirubin level 2 mg/dL baseline 6 . Patients brain spinal cord metastases 7 . Patients high risk spinal cord compression bone metastasis . 8 . Received investigational drug within period 90 day prior enrollment study 9 . Received study medication previously 10 . Currently take testosterone , testosteronelike agent antiandrogens , include 5alpha reductase inhibitor ( subject may consider randomization 4 week washout period prior randomization ) 11 . Currently take Saw Palmetto PCSPES ( subject may consider randomization 4 week washout period prior randomization ) 12 . Have take diethylstilbestrol estrogen product within previous 12 month prior randomization study 13 . Have take body build fertility supplement within 4 week admission study ( steroids steroid like supplement ) 14 . Have history cancer prostate cancer , superficial bladder cancer ( recurrence last 5 year ) and/or nonmelanoma carcinoma skin . 15 . QTcB &gt; 480 msec , If first QTcB reading exceed 480 msec two additional ECGs perform separate least 5 min apart , take average three QTcB reading determine subject satisfies criterion . If average QTcB reading &gt; 480 msec subject exclude .</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>